MARATTO

article · Malaysian Journal of Science and Advanced Technology

Quantum Support Vector Machines for Early Detection of Neurodegenerative Disorders Using Multimodal Brain Imaging

2025Open accessOsun State University

Abstract

The prompt detection of neurodegenerative diseases (NDDs) like Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), and Parkinson's Disease (PD) is essential yet difficult. This research proposes a hybrid quantum-classical machine learning methodology to categorize NDD using multimodal brain imaging data.ADNI and PPMI datasets' MRI, PET, and fMRI images were preprocessing by Python-based tools such as Scikit-image, SimpleITK, and FreeSurfer via Nipype. Major steps were denoising, registration, normalization, segmentation, and extraction of features from structural and functional imaging. Training was done with a Quantum Support Vector Machine (QSVM) using Qiskit's ZZFeatureMap and QuantumKernel and compared with a conventional SVM. Performance measures-precision, recall, F1-score, class accuracy, AUC, and 10-fold cross-validation-were calculated. QSVM performed better than the standard SVM on all metrics, with 91.25% overall accuracy and macro F1-score of 0.913 as opposed to 87.75% and 0.879 for the SVM. The results validate QSVM's advantage in handling complex, high-dimensional neuroimaging data and its relevance to aiding clinical diagnosis. Keywords: Quantum Machine Learning, Neuroimaging, QSVM, Alzheimer’s Disease, Parkinson’s Disease, Multimodal Classification

Research topics

  • Brain Tumor Detection and Classification
  • Machine Learning in Healthcare
  • Big Data and Digital Economy

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.56532/mjsat.v5i3.523

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.